Lecture 1 Flashcards
What is pharmacogenetics?
The study of inherited differences in drug metabolism and response
Pharmacogenetics focuses on how genetic variations affect individual responses to drugs.
What are the four main processes involved in drug disposition?
- Absorption
- Distribution
- Metabolism
- Excretion
These processes are collectively referred to as ADME.
Define genetic polymorphism.
The presence of two or more clearly different traits in the same population
Genetic polymorphisms can include nucleobase variants (SNPs), indels, and gene deletions.
What is the effect of inherited variation in cytochrome P450 (CYP) enzymes?
It can lead to differences in drug metabolism and response
CYP enzymes are crucial for the metabolism of many drugs.
What does the term ‘poor metaboliser’ refer to?
An inherited loss of function in a drug metabolising enzyme leading to null enzyme activity
Poor metabolizers may experience elevated drug levels and increased risk of adverse effects.
What is the prevalence of the poor metaboliser phenotype in European populations?
~3%
This low prevalence is important for understanding the risk of adverse drug reactions in these populations.
Fill in the blank: The major drug metabolising CYP families are CYP1, CYP2, and _______.
CYP3
Each family contains multiple subfamilies and individual isoforms.
What is the significance of the CYP gene name format?
The gene name is italicized while the protein name is in normal case
This distinction helps in identifying genetic variants and their functions.
True or False: A variant allele may result from a single nucleotide change (SNP).
True
Variants can also arise from combinations of SNPs, gene duplications, or deletions.
What are the possible outcomes of inherited variation in drug metabolism?
- Increased drug efficacy
- Increased risk of toxicity
- Altered therapeutic response
These outcomes can significantly affect patient treatment plans.
What is the effect of being a poor metaboliser of omeprazole?
Elevated plasma concentrations due to decreased hepatic clearance
Poor metabolizers may require careful monitoring to avoid toxicity.
Define the term ‘extensive metaboliser’.
An individual homozygous for the wild type allele with normal enzyme function
Extensive metabolizers typically have drug levels within the expected therapeutic range.
What does the abbreviation AUC stand for in pharmacokinetics?
Area Under the Curve
AUC measures drug exposure over time and is critical for understanding drug clearance.
Which CYP enzyme is primarily responsible for the metabolism of omeprazole?
CYP2C19
Variants in CYP2C19 can significantly affect omeprazole plasma concentrations.
Fill in the blank: The phenotype of an individual with two null function alleles for CYP2C19 is _______.
Poor metaboliser (PM)
PM individuals may have significantly higher drug levels due to inefficient metabolism.
What is the inheritance pattern of the poor metaboliser phenotype?
Autosomal co-dominant Mendelian manner
This means both alleles contribute to the phenotype.
What is the role of ABCC11 in ear wax production?
It is a transporter (efflux pump) responsible for cerumen secretion
Variants in this gene can lead to different ear wax types (wet or dry).
What is the clinical importance of genetic polymorphisms in CYP enzymes?
They can influence drug metabolism and risk of adverse drug reactions
Understanding these polymorphisms is essential for personalized medicine.
What are the potential consequences of inherited variation on drug safety?
- Increased risk of adverse drug reactions
- Variability in therapeutic efficacy
- Need for dose adjustments
These factors highlight the importance of pharmacogenetic testing.
What is the definition of a Poor Metaboliser (PM) in pharmacogenomics?
A Poor Metaboliser (PM) has a significantly reduced ability to metabolize certain drugs due to genetic variations.
What does CYP2C19 genotype correlate with in relation to omeprazole?
CYP2C19 genotype correlates with omeprazole plasma concentrations.
What is the significance of the *17 allele in CYP2C19?
CYP2C19 *17 carriers have higher clearance rates, which may lead to sub-therapeutic plasma concentrations.